William Lewis - 06 Jan 2022 Form 4 Insider Report for INSMED Inc (INSM)

Role: Chair and CEO, Director
Signature: /s/ William Lewis, by Michael Smith as Attorney in Fact
Issuer symbol: INSM
Transactions as of: 06 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Jan 2022, 16:06:36 UTC
Previous filing: 07 Jan 2022
Next filing: 13 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSM	Common Stock	Award		+30,741	+16%		220,497	06 Jan 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSM	Stock Option (right to buy)	Award	$0	+148,540		$0.000000	148,540	06 Jan 2022	Common Stock	148,540	$26.43	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.
F2	Each Restricted Stock Unit was received as a grant on January 6, 2022, for no consideration.
F3	Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.